Vitamin D and Parkinson's disease (Q38038831)

27 August 2017

Vitamin D and Parkinson's disease (English)

1 reference

27 August 2017

0 references

Khanh Vinh Quôc Luong

series ordinal

1

1 reference

PubMed ID

22930493

27 August 2017

Lan Thi Hoàng Nguyên

series ordinal

2

1 reference

27 August 2017

28 August 2012

1 reference

Journal of Neuroscience Research

27 August 2017

1 reference

27 August 2017

90

1 reference

27 August 2017

12

1 reference

27 August 2017

2227-2236

1 reference

Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells

27 August 2017

1 reference

Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra

21 January 2018

1 reference

Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.

21 January 2018

1 reference

Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man

21 January 2018

1 reference

1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells

21 January 2018

1 reference

α-Synuclein Alters Toll-Like Receptor Expression

21 January 2018

1 reference

Behavioural characterization of vitamin D receptor knockout mice

21 January 2018

1 reference

Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine

21 January 2018

1 reference

Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a

21 January 2018

1 reference

Systemic vitamin D3 attenuated oxidative injuries in the locus coeruleus of rat brain

21 January 2018

1 reference

Regulation of alpha-synuclein expression by liver X receptor ligands in vitro

21 January 2018

1 reference

NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease

21 January 2018

1 reference

The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death

21 January 2018

1 reference

Maternal vitamin D deficiency alters the expression of genes involved in dopamine specification in the developing rat mesencephalon.

21 January 2018

1 reference

Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease

21 January 2018

1 reference

The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration.

21 January 2018

1 reference

Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes

21 January 2018

1 reference

The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.

21 January 2018

1 reference

Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease

21 January 2018

1 reference

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain

21 January 2018

1 reference

Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease

21 January 2018

1 reference

Developmental Vitamin D3 deficiency alters the adult rat brain.

21 January 2018

1 reference

Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations

21 January 2018

1 reference

Regional and hormone-dependent effects of apolipoprotein E genotype on changes in bone mineral in perimenopausal women

21 January 2018

1 reference

Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.

21 January 2018

1 reference

Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease

21 January 2018

1 reference

An estimate of the global reduction in mortality rates through doubling vitamin D levels

21 January 2018

1 reference

Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.

21 January 2018

1 reference

1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro

21 January 2018

1 reference

Effect of active vitamin D3 on the levels of NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine-binding protein

21 January 2018

1 reference

Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury

21 January 2018

1 reference

Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.

21 January 2018

1 reference

MAP kinase signaling cascades and gene expression in osteoblasts.

21 January 2018

1 reference

Total cholesterol and the risk of Parkinson disease

21 January 2018

1 reference

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease

21 January 2018

1 reference

Apolipoprotein E and dementia in Parkinson disease: a meta-analysis.

21 January 2018

1 reference

Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study

21 January 2018

1 reference

APOE ε4 is associated with higher vitamin D levels in targeted replacement mice and humans

21 January 2018

1 reference

Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats

21 January 2018

1 reference

Effects of paricalcitol and enalapril on atherosclerotic injury in mouse aortas

21 January 2018

1 reference

Emerging roles of Wnts in the adult nervous system

21 January 2018

1 reference

The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease

21 January 2018

1 reference

Vulnerability to glutamate toxicity of dopaminergic neurons is dependent on endogenous dopamine and MAPK activation.

21 January 2018

1 reference

Age-dependent dopaminergic dysfunction in Nurr1 knockout mice

21 January 2018

1 reference

Inhibition of LXRalpha signaling by vitamin D receptor: possible role of VDR in bile acid synthesis

21 January 2018

1 reference

Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease

21 January 2018

1 reference

Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.

21 January 2018

1 reference

Outdoor work and risk for Parkinson's disease: a population-based case-control study

21 January 2018

1 reference

Control of motoneuron survival by angiogenin.

21 January 2018

1 reference

Serum vitamin D and the risk of Parkinson disease

21 January 2018

1 reference

Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease

21 January 2018

1 reference

6-Hydroxydopamine induces mitochondrial ERK activation.

21 January 2018

1 reference

Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity.

21 January 2018

1 reference

Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis

21 January 2018

1 reference

Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts

21 January 2018

1 reference

BCG vaccination: a role for vitamin D?

21 January 2018

1 reference

Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.

21 January 2018

1 reference

Decreased NURR1 gene expression in patients with Parkinson's disease

21 January 2018

1 reference

Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease

21 January 2018

1 reference

Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.

21 January 2018

1 reference

Interleukin-10 promoter polymorphisms in Chinese patients with Parkinson's disease.

21 January 2018

1 reference

Apolipoprotein E controls the risk and age at onset of Parkinson disease

21 January 2018

1 reference

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils

21 January 2018

1 reference

Role of vitamin d in Parkinson's disease

21 January 2018

1 reference

The role of autophagy in Parkinson's disease.

21 January 2018

1 reference

The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease

21 January 2018

1 reference

The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1alpha,25(OH)2D3 target genes

21 January 2018

1 reference

1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells

21 January 2018

1 reference

LRRK2 inhibition attenuates microglial inflammatory responses

21 January 2018

1 reference

Identification of the nucleolar targeting signal of human angiogenin

21 January 2018

1 reference

Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease

21 January 2018

1 reference

Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease

21 January 2018

1 reference

22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.

21 January 2018

1 reference

Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

21 January 2018

1 reference

Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord.

21 January 2018

1 reference

Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells

21 January 2018

1 reference

Interleukin-10 protects lipopolysaccharide-induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase.

21 January 2018

1 reference

Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes

21 January 2018

1 reference

Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling

21 January 2018

1 reference

Angiogenin variation and Parkinson disease

21 January 2018

1 reference

Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis

21 January 2018

1 reference

Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells

21 January 2018

1 reference

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

21 January 2018

1 reference

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

21 January 2018

1 reference

Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns.

21 January 2018

1 reference

1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

21 January 2018

1 reference

High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease

21 January 2018

1 reference

Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine

21 January 2018

1 reference

IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons

21 January 2018

1 reference

A neuroprotective role for angiogenin in models of Parkinson's disease

21 January 2018

1 reference

Effect of vitamin D deficiency and 1,25-dihydroxyvitamin D3 on rat heart metabolism.

21 January 2018

1 reference

p38 MAPK regulates calcium signal-mediated lipid accumulation through changing VDR expression in primary preadipocytes of mice.

21 January 2018

1 reference

Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line

21 January 2018

1 reference

Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

21 January 2018

1 reference

1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo.

21 January 2018

1 reference

Statins of different brain penetrability differentially affect CSF PLTP activity.

21 January 2018

1 reference

Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease.

21 January 2018

1 reference

Statin use and the risk of Parkinson disease

21 January 2018

1 reference

Serum cholesterol and expression of ApoAI, LXRbeta and SREBP2 in vitamin D receptor knock-out mice.

21 January 2018

1 reference

Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats

21 January 2018

1 reference

Effect of transplantation of c17.2 cells transfected with interleukin-10 gene on intracerebral immune response in rat model of Parkinson's disease.

21 January 2018

1 reference

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

21 January 2018

1 reference

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

21 January 2018

1 reference

Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease

21 January 2018

1 reference

The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model

21 January 2018

1 reference

Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3).

21 January 2018

1 reference

BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease

21 January 2018

1 reference

RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements

21 January 2018

1 reference

Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.

21 January 2018

1 reference

Dopamine neuron agenesis in Nurr1-deficient mice

21 January 2018

1 reference

Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity

21 January 2018

1 reference

Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1.

21 January 2018

1 reference

Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease.

21 January 2018

1 reference

A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease.

21 January 2018

1 reference

Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox.

21 January 2018

1 reference

Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases

21 January 2018

1 reference

Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases

21 January 2018

1 reference

Overview of tyrosine hydroxylase in Parkinson's disease

21 January 2018

1 reference

Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10.

21 January 2018

1 reference

MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation – relevance in a mouse model of Parkinson’s disease

21 January 2018

1 reference

Serum Cholesterol Levels and the Risk of Parkinson's Disease

21 January 2018

1 reference

High Prevalence of Hypovitaminosis D Status in Patients With Early Parkinson Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.23115

1 reference

27 August 2017

1 reference

PubMed ID

22930493